12/19/2024
6:38 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:15 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
6:07 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:15 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
House David Duane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
3:15 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
3:33 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
6:50 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
3:15 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
House David Duane (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/15/2024
4:00 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:20 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
3:15 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for APHB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ampliphi Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
06/28/2024
5:12 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Kyme Pierre (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/07/2024
3:25 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024
7:00 AM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
3:20 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
3:15 PM | Ampliphi Biosciences (Filer)
Armata Pharmaceuticals, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
7:00 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Birx Deborah (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:00 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Odysseas Kostas D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:01 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Haimovitz Jules (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:02 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Schlesinger Sarah J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:02 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Rychlik Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:03 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Peterson Todd C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:03 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
Kramer Robin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
7:05 PM | Ampliphi Biosciences (Issuer)
Armata Pharmaceuticals, Inc. (Issuer)
PATTI JOSEPH M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:35 PM | Ampliphi Biosciences (Subject)
Armata Pharmaceuticals, Inc. (Subject)
Innoviva, Inc. (Filed by)
| Form SC 13D/A | |
Free APHB Stock Alerts